loading

Perché le azioni Scilex Holding Company (SCLX) sono in ribasso?

Abbiamo notato un calo di 10.21% nelle azioni di Scilex Holding Company (SCLX) durante la sessione di negoziazione di 2024-05-10. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-09-18:

Scilex Holding Company (SCLX) shares dipped 12.00% to $1.98. Scilex recently announced the completion of its SP-103 Phase 2 study to evaluate the safety and efficacy in subjects with acute LBP.

https://www.benzinga.com/news/23/09/34694939/canopy-growth-docgo-and-other-big-stocks-moving-lower-on-monday

2023-04-28:

Scilex Holding Company Stock (SCLX) dropped by 29.3% from $10.27 to $7.26 in the trading on Monday April 28, 2023. The reason why SCLX stock down today is due to stock sale plan and Sorrento bankruptcy update. The company, which is majority owned by Sorrento Therapeutics, said late last week that it planned to sell $300 million worth of stock. On top of that, Sorrento was told by a bankruptcy court in Texas that it had extended the expiration of the restrictions on transfer on the shares of common stock of Scilex that were distributed by Sorrento to its stockholders as a dividend on Jan. 19. The continued uncertainty regarding its parent company and likely dilution of Scilex stock will continue to weigh on the stock.

drug_manufacturers_general BMY
$44.03
price down icon 0.18%
drug_manufacturers_general GSK
$44.98
price up icon 0.22%
drug_manufacturers_general SNY
$48.67
price down icon 0.31%
drug_manufacturers_general PFE
$28.64
price down icon 0.97%
$312.47
price down icon 0.71%
drug_manufacturers_general NVS
$102.57
price down icon 0.12%
Capitalizzazione:     |  Volume (24 ore):